Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
This breakthrough could fundamentally change how we treat diabetic patients with peripheral artery disease, poor circulation in mainly the legs
Semaglutide is prescribed for lowering blood sugar levels for individuals with type 2 diabetes (T2D) and weight management for those who are overweight or have obesity with at least one weight-related comorbidity.[1-5] Individuals taking semaglutide may lose up to 15% of their body weight.[5] However, weight loss results may vary depending on your starting weight, comorbidities, other medications, and lifestyle choices.[1-5] Although the exact mechanism by which semaglutide causes weight loss is still under investigation, it has the potential to reduce appetite, thereby reducing caloric intake.[1-3] You may feel more tired than usual due to the reduced calorie intake while taking semaglutide
When to seek medical advice : Patients should contact their GP or diabetes specialist nurse if they experience: Severe, persistent vomiting preventing adequate fluid intake (risk of dehydration and acute kidney injury) Severe abdominal pain, particularly if radiating to the back (potential pancreatitisrare but serious) Right upper abdominal pain, fever, or yellowing of skin/eyes (potential gallbladder disease) Sudden vision changes (particularly with semaglutide, which may worsen diabetic retinopathy, especially with rapid HbA1c reduction) [40] [41] Signs of hypoglycaemia when used with insulin or sulphonylureas Allergic reactions (rash, difficulty breathing, facial swelling)call 999 or go to A&E for severe allergic reactions Patients should report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
It is not licensed by the MHRA, is not available on NHS prescription, and has not been appraised by NICE for any indication
